NCT06239831 Postoperative Respiratory and Activity Monitoring
| NCT ID | NCT06239831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Hypoventilation |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-12-22 |
| Primary Completion | 2025-12-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2022-12-22 with a primary completion date of 2025-12-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study plans to learn more about specific breathing and activity recommendations for patients after surgery. Participants will be monitored after abdominal surgery to identify what activities help them breathe better and reduce complications after surgery.
Eligibility Criteria
Inclusion Criteria: * Must be 18 or older * Must be undergoing abdominal surgery * Must be high-risk for PPCs (ARISCAT score equal to or greater than 26) Exclusion Criteria: * Anyone under 18 * Anyone not undergoing abdominal surgery * Anyone that is not high-risk for PPCs (ARISCAT score less than 26)
Contact & Investigator
Ana Fernandez-Bustamante, MD, PhD
PRINCIPAL INVESTIGATOR
University of Colorado Anschutz Medical Campus, University of Colorado Health Hospital
Frequently Asked Questions
Who can join the NCT06239831 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Hypoventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239831 currently recruiting?
Yes, NCT06239831 is actively recruiting participants. Contact the research team at emily.helmer@cuanschutz.edu for enrollment information.
Where is the NCT06239831 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT06239831 clinical trial?
NCT06239831 is sponsored by University of Colorado, Denver. The principal investigator is Ana Fernandez-Bustamante, MD, PhD at University of Colorado Anschutz Medical Campus, University of Colorado Health Hospital. The trial plans to enroll 30 participants.